A carregar...
Administration of a Sigma Receptor Agonist Delays MCAO-Induced Neurodegeneration and White Matter Injury
Many pharmacological treatments for stroke have afforded protection in rodent models but failed to show efficacy in clinical trials. This discrepancy may be due to the lack of long-term functional studies. Previously, delayed administration of the sigma receptor agonist 1,3-di-o-tolylguanidine (DTG)...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2885737/ https://ncbi.nlm.nih.gov/pubmed/20563232 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-009-0005-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|